← Leaderboards
Kimberly Gold Blumenthal
Massachusetts General Hospital
$4,876,153
Attributed
$8,972,946
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4M · FY2016–25$5M$3.8M$2.5M$1.3M$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,725,268 · 3
AHRQ$1,247,678 · 1
By mechanism
U01$6,518,237 · 1
R01$1,247,678 · 1
K01$779,360 · 1
UG3$427,671 · 1
Top collaborators
- Alysse Gail Wurcel4 shared
- David A Khan3 shared
- Michelle E Conroy2 shared
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Emily Beth Wong$1,124,198
- Ashwin N Ananthakrishnan$4,084,397
- Tianhong Dai$5,096,106
- Roy H Perlis$23,588,460
- Christy Elaine Cauley$485,933
Others in their field
Top investigators on “Allergic”
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$298,740,071
- James E. Gern · University Of Wisconsin-Madison$67,157,741
- David T Mauger · Pennsylvania State Univ Hershey Med Ctr$60,852,292
- Jane Hoyt Buckner · Benaroya Research Inst At Virginia Mason$54,646,353
- Mark S Anderson · University Of California, San Francisco$50,628,567
- Robert A Wood · Johns Hopkins University$43,071,509
Research focus
AllergicReportingDrug HypersensitivityReactionAllergic ReactionBeta-LactamsPenicillinsAntibioticsHypersensitivity Skin TestingMediatingUnited States National Institutes Of HealthPenicillin AllergyPharmaceutical PreparationsPerioperativeNational Institute Of Allergy And Infectious DiseaseCephalosporinsEvaluationSiteClinical EpidemiologyEpidemiologyDatabasesMentorshipRecording Of Previous EventsPhenotype
Grant awards (15)
Optimizing the diagnostic approach to cephalosporin allergy testing (DACAT Trial)$2,265,746
U01 · FY2025 · AI · contact PI
Optimizing the diagnostic approach to cephalosporin allergy testing (DACAT Trial)$1,017,955
U01 · FY2025 · AI · contact PI
Antibiotic Allergy: Phenotypes, Endotypes, and Mechanisms$351,394
UG3 · FY2025 · AI · contact PI
Improving Equitable Access to Penicillin Allergy De-Labeling$249,967
R01 · FY2025 · HS · contact PI
Antibiotic Allergy: Phenotypes, Endotypes, and Mechanisms$76,277
UG3 · FY2025 · AI · contact PI
Optimizing the diagnostic approach to cephalosporin allergy testing (DACAT Trial)$3,234,536
U01 · FY2024 · AI · contact PI
Improving Equitable Access to Penicillin Allergy De-Labeling$496,080
R01 · FY2024 · HS · contact PI
Improving Equitable Access to Penicillin Allergy De-Labeling$3,853
R01 · FY2024 · HS · contact PI
Improving Equitable Access to Penicillin Allergy De-Labeling$497,778
R01 · FY2023 · HS
The Clinical and Economic Impact of Penicillin Allergy$95,426
K01 · FY2021 · AI · contact PI
The Clinical and Economic Impact of Penicillin Allergy$137,160
K01 · FY2020 · AI · contact PI
The Clinical and Economic Impact of Penicillin Allergy$136,892
K01 · FY2019 · AI · contact PI
The Clinical and Economic Impact of Penicillin Allergy$136,892
K01 · FY2018 · AI · contact PI
The Clinical and Economic Impact of Penicillin Allergy$136,624
K01 · FY2017 · AI · contact PI
The Clinical and Economic Impact of Penicillin Allergy$136,366
K01 · FY2016 · AI · contact PI